20th Biosimilars Congregation 2025
“Where Biosimilar leaders meet Innovation Strategy & Success”
11th December 2025 Kohinoor Continental Hotel Mumbai India
This year we place a strong focus on the evolving dynamics of biologics market competition with an emphasis on building a sustainable and competitive framework for biosimilars. Key themes include pricing strategies procurement practices and regional efforts to ensure long-term sustainability and accessibility. We’ll explore the critical factors influencing biosimilar uptake—and what lies beyond it. Global policymakers and industry leaders will share actionable insights and collaborative strategies to foster access affordability and innovation in biological treatments. The high-level conference sessions are designed to equip you with the latest business models regulatory updates and market strategies. You’ll gain invaluable opportunities to benchmark your approach against industry frontrunners and develop immediate action plans in response to challenges like R&D costs regulatory barriers and market entry hurdles—all against the backdrop of rising commercial potential.
It is our great pleasure to welcome you to this influential platform. We hope that the insights shared and connections made here will benefit not only your organization but the broader healthcare ecosystem. We wish and pray that you have a rewarding & impactful experience at our 20th Biosimilars Congregation 2025.
Sponsor / Delegate Registration E-mail - [email protected] or M: +91 9361957193
SPONSORSHIP:
Exhibitor – Medclinica
Conference Sponsor & Exhibition Stall – Should you wish to Sponsor or purchase a Exhibition Stall (Booth) or a paid Speaker Slot you can simply email your interest and queries.
DELEGATE REGISTRATION:
Super Early Bird Price (Valid until 31 Oct 2025) –11000 + GST 18% per delegate
Early Bird Price (Valid until 1st Nov – 28th Nov) –14000 + GST 18% per delegate
Standard Price (Valid from 29 Nov 2025) - INR 16000 + GST 18% per delegate.
KEY SPEAKERS:
DEBASHIS SARKAR Senior VP & Head Emerging MarketsAurobindo
SANJEEV GUPTA Sr. Vice President & Head Biosimilar Ipca Laboratories
SUMITA MOHAPATRO PANI Sr. VP & Head - Business Development & Inlicensing Business Ethics & ComplianceLupin
HANMANT BARKATE Group VP & Global Head - Medical Affairs Glenmark
ABHISHEK SINHA VP Global Regulatory AffairsAdvanz Pharma
MANNAN KHAMBATI VP Biotech Manufacturing Bharat Serums and Vaccines
VIKAS VAISHNAVI Director Program Patient Safety Sandoz
SONALI KHANRA Associate Director RWE Novartis
MILIND ANTANI Leader Pharma & HealthcareNishith Desai Associates
AMARNATH SUGUMARAN Associate Director & Cluster Head Medical Affairs Cipla
SANTOSH TAUR Director Medical Affairs Vaccines Rare Diseases & Digital Pfizer
AMARNATH CHATTERJEE Director & Head Analytical Sciences & QCCipla
SOURABH FULMALI Global Medical DirectorGSK
RAVI SAILAPPAN Head – EPD Quality Systems Abbott
SANJAY B NIRANJAN Assistant Director Bioassay Development (Biosimilars)Lupin
SHUVANKAR BALLAV Head Regulatory Affairs - Advanced Biotech Lab (ABL) Ipca Laboratories
SAMIR KULKARNI Head - DBT ICT Center Institute of Chemical Technology
AKSHAYA ODAK Head - Regulatory Affairs (Biotech) Lupin
SWEETY MATTHEW Regulatory Professional- Global Regulatory Affairs: CMC Rare DiseasesNovo Nordisk
SEEMA BHANDARKAR Commercial Head CIS & Russia Biosimilars Biocon
APARNA PRABHUNE Deputy GM – Regulatory AffairsWockhardt
MAYUR MAYBHATE Head Medical Affairs Alkem Laboratories
KAVITA LAMROR Partner RWE & Digital TransformationMaxis Clinical Sciences
KHOKAN DEBNATH Sr GM / (Head) – Regulatory Affairs Clinical Operations PV QA & Compliance (India & Emerging Market) Wockhardt
KHUSHBOO PANCHAL Business Strategy Manager - Asia Pacific RegionMSD
VISHWAS SOVANI Founder Director Pharmawisdom
Plus more joining soon
KEY THEMES:
Regulatory Updates & Policy Shifts
Market Access Pricing & Affordability Strategies
Cost Competitiveness vs. Global Players
Scaling Manufacturing / Development / Commercialisation
Export Growth & Global Market Alignment
Next-Gen Biosimilars & Technological Innovation
Role & Expectations of Payers
Patent Landscape & IP Navigation in India
Real-World Evidence (RWE) & PMS in India
Patient Awareness & Education Initiatives
Physician Trust & Clinical Confidence Building
Quality Standards & Biosimilar Pharmacovigilance
Digital Tools in Biosimilar R&D and Process Monitoring
What’s the way forward? / Opportunity - Learn & Network
WHO SHOULD ATTEND AND WHO YOU’LL MEET:
CSOs CMOs Vice Presidents Presidents Heads Directors Team Leaders and Senior Scientists from the following roles;
Biopharmaceuticals/ Biotherapeutics Follow on Biologics/Follow on Proteins Biologics/Biotechnology/ Bio generics Legal Affairs Intellectual Property Health Economics Pricing and Reimbursement Clinical Immunology Principal Scientist Chief Scientific Officer Process Control and Analytical Technologies Analytical Characterisation Regulatory Quality Affairs/ Quality Control New Product Development Process Science Portfolio Management Research & Development Business Development Business Operations Scientific Affairs Commercial Affairs
Get more from this year’s event with a broader scope that unites the entire communications and biosimilars value chain. Take full advantage of our dedicated networking sessions and explore cutting-edge innovations at the co-located exhibition where leading international vendors showcase the products of tomorrow.
Event Venue & Nearby Stays
Hotel Kohinoor Continental, Mumbai, India
